Estradiol and vitamin D exert a synergistic effect on preventing osteoporosis via the miR-351-5p/IRS1 axis and mTOR/NFκB signaling pathway

Abstract This study aimed to investigate the antiosteoporotic effects and regulatory mechanisms of estradiol (E2) and vitamin D. MC3T3-E1 cells were treated with E2, vitamin D, or their combination, followed by a systematic assessment of cell proliferation and osteogenic differentiation capacity acr...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaoyan Dai, Changcun Liu, Wenkai Bi, Guiwen Zheng, Kuan Lv, Zhiming Xia
Format: Article
Language:English
Published: Nature Portfolio 2025-05-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-02808-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849704233498050560
author Xiaoyan Dai
Changcun Liu
Wenkai Bi
Guiwen Zheng
Kuan Lv
Zhiming Xia
author_facet Xiaoyan Dai
Changcun Liu
Wenkai Bi
Guiwen Zheng
Kuan Lv
Zhiming Xia
author_sort Xiaoyan Dai
collection DOAJ
description Abstract This study aimed to investigate the antiosteoporotic effects and regulatory mechanisms of estradiol (E2) and vitamin D. MC3T3-E1 cells were treated with E2, vitamin D, or their combination, followed by a systematic assessment of cell proliferation and osteogenic differentiation capacity across the treatment groups. Subsequently, miRNA sequencing was performed to analyze differentially expressed miRNAs between the control and E2&vitamin D groups. The target relationship between miR-351-5p and IRS1 was validated, and the effects of the miR-351-5p/IRS1 axis on osteogenesis and mTOR/NFκB signaling pathway were determined after combination treatment. Additionally, an ovariectomized (OVX) osteoporosis mouse model was established to ‌systematically examine‌ the effects of E2, vitamin D, and their combination on osteoporosis and mTOR/NFκB signaling pathway. E2 and vitamin D synergistically promoted MC3T3-E1 cell proliferation and osteogenic differentiation. miR-351-5p was identified through miRNA sequencing analysis. miR-351-5p was downregulated in MC3T3-E1 cells after E2 and vitamin D combination treatment, and its overexpression partially reversed the effect of the combination treatment on osteogenesis. IRS1 was a target of miR-351-5p. When overexpressed, IRS1 partially mitigated the impact of miR-351-5p overexpression on osteogenesis and mTOR/NFκB signaling pathway under the combination treatment. Furthermore, in vivo experiments demonstrated that E2 and vitamin D could synergistically prevent osteoporosis in OVX mice by inhibiting the mTOR/NFκB signaling pathway. In conclusion, E2 and vitamin D exhibited a synergistic effect in preventing osteoporosis through the miR-351-5p/IRS1 axis and mTOR/NFκB signaling pathway. E2 and vitamin D combination treatment could be a potential anti-osteoporotic strategy for osteoporosis treatment.
format Article
id doaj-art-6f42a7d333c242aa8c6780b3fa20b174
institution DOAJ
issn 2045-2322
language English
publishDate 2025-05-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-6f42a7d333c242aa8c6780b3fa20b1742025-08-20T03:16:50ZengNature PortfolioScientific Reports2045-23222025-05-0115111410.1038/s41598-025-02808-zEstradiol and vitamin D exert a synergistic effect on preventing osteoporosis via the miR-351-5p/IRS1 axis and mTOR/NFκB signaling pathwayXiaoyan Dai0Changcun Liu1Wenkai Bi2Guiwen Zheng3Kuan Lv4Zhiming Xia5Department of Otolaryngology, Shandong Provincial Hospital Affiliated to Shandong First Medical UniversityDepartment of Nuclear Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineDepartment of Nuclear Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical UniversityDepartment of Nuclear Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical UniversityDepartment of Nuclear Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical UniversityDepartment of Nuclear Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical UniversityAbstract This study aimed to investigate the antiosteoporotic effects and regulatory mechanisms of estradiol (E2) and vitamin D. MC3T3-E1 cells were treated with E2, vitamin D, or their combination, followed by a systematic assessment of cell proliferation and osteogenic differentiation capacity across the treatment groups. Subsequently, miRNA sequencing was performed to analyze differentially expressed miRNAs between the control and E2&vitamin D groups. The target relationship between miR-351-5p and IRS1 was validated, and the effects of the miR-351-5p/IRS1 axis on osteogenesis and mTOR/NFκB signaling pathway were determined after combination treatment. Additionally, an ovariectomized (OVX) osteoporosis mouse model was established to ‌systematically examine‌ the effects of E2, vitamin D, and their combination on osteoporosis and mTOR/NFκB signaling pathway. E2 and vitamin D synergistically promoted MC3T3-E1 cell proliferation and osteogenic differentiation. miR-351-5p was identified through miRNA sequencing analysis. miR-351-5p was downregulated in MC3T3-E1 cells after E2 and vitamin D combination treatment, and its overexpression partially reversed the effect of the combination treatment on osteogenesis. IRS1 was a target of miR-351-5p. When overexpressed, IRS1 partially mitigated the impact of miR-351-5p overexpression on osteogenesis and mTOR/NFκB signaling pathway under the combination treatment. Furthermore, in vivo experiments demonstrated that E2 and vitamin D could synergistically prevent osteoporosis in OVX mice by inhibiting the mTOR/NFκB signaling pathway. In conclusion, E2 and vitamin D exhibited a synergistic effect in preventing osteoporosis through the miR-351-5p/IRS1 axis and mTOR/NFκB signaling pathway. E2 and vitamin D combination treatment could be a potential anti-osteoporotic strategy for osteoporosis treatment.https://doi.org/10.1038/s41598-025-02808-zOsteoporosisEstradiolVitamin DmiR-351-5pIRS1mTOR/NFκB signaling pathway
spellingShingle Xiaoyan Dai
Changcun Liu
Wenkai Bi
Guiwen Zheng
Kuan Lv
Zhiming Xia
Estradiol and vitamin D exert a synergistic effect on preventing osteoporosis via the miR-351-5p/IRS1 axis and mTOR/NFκB signaling pathway
Scientific Reports
Osteoporosis
Estradiol
Vitamin D
miR-351-5p
IRS1
mTOR/NFκB signaling pathway
title Estradiol and vitamin D exert a synergistic effect on preventing osteoporosis via the miR-351-5p/IRS1 axis and mTOR/NFκB signaling pathway
title_full Estradiol and vitamin D exert a synergistic effect on preventing osteoporosis via the miR-351-5p/IRS1 axis and mTOR/NFκB signaling pathway
title_fullStr Estradiol and vitamin D exert a synergistic effect on preventing osteoporosis via the miR-351-5p/IRS1 axis and mTOR/NFκB signaling pathway
title_full_unstemmed Estradiol and vitamin D exert a synergistic effect on preventing osteoporosis via the miR-351-5p/IRS1 axis and mTOR/NFκB signaling pathway
title_short Estradiol and vitamin D exert a synergistic effect on preventing osteoporosis via the miR-351-5p/IRS1 axis and mTOR/NFκB signaling pathway
title_sort estradiol and vitamin d exert a synergistic effect on preventing osteoporosis via the mir 351 5p irs1 axis and mtor nfκb signaling pathway
topic Osteoporosis
Estradiol
Vitamin D
miR-351-5p
IRS1
mTOR/NFκB signaling pathway
url https://doi.org/10.1038/s41598-025-02808-z
work_keys_str_mv AT xiaoyandai estradiolandvitamindexertasynergisticeffectonpreventingosteoporosisviathemir3515pirs1axisandmtornfkbsignalingpathway
AT changcunliu estradiolandvitamindexertasynergisticeffectonpreventingosteoporosisviathemir3515pirs1axisandmtornfkbsignalingpathway
AT wenkaibi estradiolandvitamindexertasynergisticeffectonpreventingosteoporosisviathemir3515pirs1axisandmtornfkbsignalingpathway
AT guiwenzheng estradiolandvitamindexertasynergisticeffectonpreventingosteoporosisviathemir3515pirs1axisandmtornfkbsignalingpathway
AT kuanlv estradiolandvitamindexertasynergisticeffectonpreventingosteoporosisviathemir3515pirs1axisandmtornfkbsignalingpathway
AT zhimingxia estradiolandvitamindexertasynergisticeffectonpreventingosteoporosisviathemir3515pirs1axisandmtornfkbsignalingpathway